Ben R. Taylor, Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 15,031 shares at $3.39 ($51K) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Scheduled sale ($51k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.42 | 7,075 | $24K | 47.3% |
| 2 | $3.39 | 7,956 | $27K | 52.7% |
| Total | $3.40 avg | 15,031 | $51K | 100% |
| Filing → |
| TYME | BUY | 2019-06-17 | $10K | — | Filing → |